They Already Told You Their Conflicts. You Just Weren’t Meant to Notice

In one of my Substacks, I argued that “conflict of interest” in tobacco control has been quietly redefined to mean one thing only: industry. Everything else, career incentives, ideological commitments, institutional loyalties, has been recast as either benign or irrelevant. The result is a field that believes it has solved the problem of bias simply by locating it in the “other.”

Now consider the latest Australian study making headlines.

On paper, it arrives with all the expected signals of credibility. University affiliations, public health framing, and the absence of any declared industry funding. By the prevailing definition, that means it is clean. Objective. Trustworthy.

But only if we keep using the narrowed definition.

Because if we apply the broader framework, the one that actually reflects how human incentives work, the conflicts do not disappear. They come into focus.

Look at the authors not as neutral observers, but as participants embedded in a system. Their careers are not floating freely above the debate. They exist within a policy environment that has already taken a firm position. Vaping is a problem to be suppressed, not a tool to be evaluated alongside smoking. Funding flows accordingly. So do media opportunities, advisory roles, and institutional prestige.

If your research consistently reinforces the dominant policy direction, you are more likely to be funded, published, cited, and amplified. If it challenges that direction, especially in a way that could undermine flagship policies, you are more likely to face friction, scrutiny, or quiet marginalisation.

That is not a moral failing. It is how systems stabilise themselves.

But it is a conflict of interest.

And it becomes particularly relevant when interpreting the kinds of conclusions we are now seeing. Ambiguity is resolved in one direction. Limitations are acknowledged but contained. Signals that complicate the narrative, declines in smoking linked to vaping uptake, substitution effects, consumer behaviour, are either backgrounded or reframed as risks.

Again, not because the authors are dishonest. But because interpretation is not a neutral act. It is shaped by priors, incentives, and the environment in which the research is produced.

What makes this more troubling is how the study is then received.

The same commentators who would immediately interrogate any industry linked research instead treat this work as epistemically settled before the discussion has even begun. The conclusions are reported as findings, not interpretations. The framing becomes the story.

And just like that, the asymmetry locks into place.

We are told, implicitly but unmistakably, that these scientists have no conflicts worth mentioning. That their perspective emerges from a kind of institutional vacuum. That only one side of this debate needs to be interrogated for bias.

But here is the uncomfortable truth. They already disclosed their conflicts.

Not in a neat “competing interests” statement, but in the structure of their careers. In the policy frameworks they operate within. In the questions they choose to ask, and the ones they do not.

You can see it in the consistency of the conclusions across studies produced by the same networks. You can see it in how quickly complex, uncertain evidence is translated into simple, morally loaded messaging. You can see it in the absence of genuine engagement with findings that point in the opposite direction.

These are not coincidences. They are signals.

And once you start looking for them, the idea that only industry funding creates bias becomes impossible to sustain.

This matters because the stakes are not academic. Australia has pursued one of the most restrictive approaches to vaping in the world. That policy rests, in part, on the authority of researchers who are presented as disinterested arbiters of evidence.

If their incentives are not examined with the same rigor applied to industry, then we are not evaluating evidence. We are enforcing a narrative.

A truly evidence based field would not be afraid of this symmetry. It would welcome it. It would ask harder questions not just of its critics, but of itself.

What institutional pressures shape our conclusions?

What career incentives reward certain findings over others?

What assumptions have we stopped noticing because they are shared by everyone around us?

Until those questions are asked openly, every new study will arrive pre interpreted. Not because the data demand it, but because the system does.

And the public, told that “conflict of interest” has already been dealt with, will have no reason to look any deeper.

But you should.

Because the conflicts are still there.

They have just been redefined out of view.